Skip to content

Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate

C25H31ClN2O2 — CID 155383113

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate
SMILESCCOC(=O)/C=C/CNCCCCCN1c2ccccc2CCc2ccc(Cl)cc21
InChIInChI=1S/C25H31ClN2O2/c1-2-30-25(29)11-8-17-27-16-6-3-7-18-28-23-10-5-4-9-20(23)12-13-21-14-15-22(26)19-24(21)28/h4-5,8-11,14-15,19,27H,2-3,6-7,12-13,16-18H2,1H3/b11-8+
InChIKeySUHHOHBXVWLYCC-DHZHZOJOSA-N
MW426.99 g/mol
LogP5.46
Rot. Bonds10

About Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate

Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate (PubChem CID 155383113) has the molecular formula C25H31ClN2O2 and a molecular weight of 426.99 g/mol. Its IUPAC name is ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate.

Molecular Properties

Compound NameEthyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate
PubChem CID155383113
Molecular FormulaC25H31ClN2O2
Molecular Weight426.99 g/mol
Exact Mass426.21
IUPAC Nameethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate
SMILESCCOC(=O)/C=C/CNCCCCCN1c2ccccc2CCc2ccc(Cl)cc21
InChIInChI=1S/C25H31ClN2O2/c1-2-30-25(29)11-8-17-27-16-6-3-7-18-28-23-10-5-4-9-20(23)12-13-21-14-15-22(26)19-24(21)28/h4-5,8-11,14-15,19,27H,2-3,6-7,12-13,16-18H2,1H3/b11-8+
InChIKeySUHHOHBXVWLYCC-DHZHZOJOSA-N
XLogP5.46
TPSA41.57 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms30
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500426.99
LogP ≤ 55.46
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate?
The IUPAC name of Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate (CID 155383113) is ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate.
What is the SMILES notation for Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate?
The canonical SMILES for Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate is CCOC(=O)/C=C/CNCCCCCN1c2ccccc2CCc2ccc(Cl)cc21.
What is the InChIKey of Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate?
The InChIKey is SUHHOHBXVWLYCC-DHZHZOJOSA-N. The full InChI is InChI=1S/C25H31ClN2O2/c1-2-30-25(29)11-8-17-27-16-6-3-7-18-28-23-10-5-4-9-20(23)12-13-21-14-15-22(26)19-24(21)28/h4-5,8-11,14-15,19,27H,2-3,6-7,12-13,16-18H2,1H3/b11-8+.
What are the key properties of Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate?
Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate has a molecular weight of 426.99 g/mol, XLogP of 5.46, 10 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for Ethyl (E)-4-[5-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)pentylamino]but-2-enoate is sourced from PubChem (CID 155383113), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.